Mark I. Greene

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Challenges in Detection of Serum Oncoprotein: Relevance to Breast Cancer Diagnostics”.

Challenges in Detection of Serum Oncoprotein: Relevance to Breast Cancer Diagnostics

Breast Cancer Targets and Therapy(2021)10.2147/bctt.s331844

N/A

0DataRank · unranked

10 citations

Hongtao Zhang, S.P. Stoesz, Ramachandran Murali, Franklin Pass, Mark I. Greene +3 more

Rational Design of Constrained Peptides as Protein Interface Inhibitors

Antibodies(2021)10.3390/antib10030032

N/A

0DataRank · unranked

5 citations

Hongtao Zhang, Zheng Cai, Lian Lam, Mark I. Greene, Ramachandran Murali

F77 antigen is a promising target for adoptive T cell therapy of prostate cancer

Biochemical and Biophysical Research Communications(2023)10.1016/j.bbrc.2023.09.018

N/A

0DataRank · unranked

7 citations

Selene Nuñez-Cruz, John Leferovich, Tyra Wentz, Atrish Bagchi, Michael C. Milone +2 more

HED, a Human-Engineered Domain, Confers a Unique Fc-Binding Activity to Produce a New Class of Humanized Antibody-like Molecules

International Journal of Molecular Sciences(2023)10.3390/ijms24076477

N/A

0DataRank · unranked

0 citations

Peeyush N. Goel, Zheng Cai, Yasuhiro Nagai, Lian Lam, Arabinda Samanta +4 more

Targeting erbB Pathways in Breast Cancer: Dual Kinase Inhibition for Brain Metastasis and Prevention of p185HER2/Neu Tumor Development

Breast Cancer Targets and Therapy(2024)10.2147/bctt.s490904

N/A

0DataRank · unranked

0 citations

Makoto Katsumata, Wei Qian, Sunil Mathur, Mei Ji, Arabinda Samanta +5 more